The First Affiliated Hospital of Chongqin Medical University
Welcome,         Profile    Billing    Logout  
 5 Trials 
1 Trials

   Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hui, Li
NCT06532058: Phase IIa Study to Assess Safety and Efficacy in the Relapsed/Refractory Acute Myeloid Leukemia

Recruiting
2
53
RoW
QHRD107 capsule,Venclexta and Azacitidine, CDK9 inhibitors
Changzhou Qianhong Bio-pharma Co., Ltd.
Relapsed/Refractory Acute Myeloid Leukemia (R/R-AML)
02/25
05/25

Download Options